Medik8 targets $100 million in sales with Sephora US and Canada debut

Medik8, the UK-founded premium skincare brand, has launched into Sephora's US and Canada stores, a debut it is framing as central to a plan to reach $100 million in sales. The move gives the brand access to Sephora's extensive North American retail and digital footprint, a distribution channel that has become the primary growth engine for prestige skincare brands seeking scale in the United States.

North America remains the largest and most closely watched beauty market globally, and Sephora's retail floor has become the proving ground for whether a premium skincare brand can translate European credibility into mass American appeal. Medik8's entry adds to a wave of British and European skincare labels using Sephora as their launchpad, reflecting how reliant premium beauty brands have become on a handful of major specialty retailers to reach new customers efficiently, rather than building out costly owned retail networks from scratch.

The scale of Medik8's ambition, a nine-figure sales target attached explicitly to this launch, suggests confidence that the brand's clinical positioning can travel well beyond its UK base. It also reflects the broader dynamic in skincare, where clean, ingredient-led, dermatologist-style branding continues to command premium pricing and strong retailer interest even as some other beauty categories cool.

What to watch: how quickly Medik8 scales its shelf presence and marketing spend in the US, and whether its performance validates Sephora North America as a reliable path for European skincare brands chasing meaningful scale.

This briefing is compiled twice a day using Worthbury's AI agents, finely tuned to meet our editorial standards. While we test and review their work, mistakes can sometimes happen. See exactly how it works.